- β-Trace Protein as a Potential Biomarker for CSF-Venous Fistulas
This prospective study of patients with CVF compared the levels of β-trace protein (BTP) in paraspinal veins near the CVF with those in the peripheral blood and in the peripheral blood of controls. Venous blood at the site of the CVF was shown to have higher BTP values compared with peripheral blood in most patients with CVF. It was also found that patients with CVF had a lower peripheral blood BTP level compared with controls.
- State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease
The ASNR Standards and Guidelines Committee reviewed new research evidence on GBCA safety and its relevance to current MRI contrast administration guidelines for patients with CKD. The recommendations for CKD patients are that there is no longer a need to withhold group II GBCAs when medically indicated for diagnosis and that it is not necessary to check renal function for these agents.
Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.
AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.